NCT03286751View on ClinicalTrials.gov

A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 13, 2017

Primary Completion Date

February 6, 2018

Study Completion Date

February 6, 2018

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

LY900014

Administered SC

DRUG

Insulin Lispro

Administered SC

Trial Locations (2)

41460

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Neuss

55116

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Mainz

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03286751 - A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy Participants | Biotech Hunter | Biotech Hunter